Rush et al., 1997 - Google Patents
Expression of vaccine antigens in LactobacillusRush et al., 1997
- Document ID
- 8134292538892199778
- Author
- Rush C
- Mercenier A
- Pozzi G
- Publication year
- Publication venue
- Gram-Positive Bacteria: Vaccine Vehicles for Mucosal Immunization
External Links
Snippet
The genus Lactobacillus comprises a remarkably diverse and heterogeneous group of Gram- positive bacilli that are ubiquitous as components of the normal indigenous flora of humans and other animals as well as being important lactic acid bacteria used for the production of …
- 241000186660 Lactobacillus 0 title abstract description 83
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—PROCESSES USING MICRO-ORGANISMS
- C12R1/00—Processes using micro-organisms
- C12R1/01—Processes using micro-organisms using bacteria or actinomycetales
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using micro-organisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using micro-organisms or enzymes using only micro-organisms of the genus lactobacteriaceae; Yoghurt
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tannock | The microecology of lactobacilli inhabiting the gastrointestinal tract | |
| Walter et al. | A high-molecular-mass surface protein (Lsp) and methionine sulfoxide reductase B (MsrB) contribute to the ecological performance of Lactobacillus reuteri in the murine gut | |
| Denou et al. | Identification of genes associated with the long-gut-persistence phenotype of the probiotic Lactobacillus johnsonii strain NCC533 using a combination of genomics and transcriptome analysis | |
| Pontes et al. | Lactococcus lactis as a live vector: heterologous protein production and DNA delivery systems | |
| Kullen et al. | Genetic modification of intestinal lactobacilli and bifidobacteria | |
| Toit et al. | Preliminary characterization of bacteriocins produced by Enterococcus faecium and Enterococcus faecalis isolated from pig faeces | |
| Tavares et al. | Novel strategies for efficient production and delivery of live biotherapeutics and biotechnological uses of Lactococcus lactis: the lactic acid bacterium model | |
| Hynönen et al. | Lactobacillus surface layer proteins: structure, function and applications | |
| Fons et al. | Isolation and Characterization of a Plasmid fromLactobacillus fermentumConferring Erythromycin Resistance | |
| Dunne et al. | Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials | |
| Vaughan et al. | The intestinal labs | |
| Neville et al. | Probiotic properties of Lactobacillus salivarius and closely related Lactobacillus species | |
| CA2738781C (en) | Reduced colonization of microbes at the mucosa | |
| Todorov et al. | Bacteriocin production and resistance to drugs are advantageous features for Lactobacillus acidophilus La-14, a potential probiotic strain | |
| Azizpour et al. | Lactococcus lactis: A new strategy for vaccination | |
| Renault | Genetically modified lactic acid bacteria: applications to food or health and risk assessment | |
| Termont et al. | Intracellular accumulation of trehalose protects Lactococcus lactis from freeze-drying damage and bile toxicity and increases gastric acid resistance | |
| Del Carmen et al. | Evaluation of the anti-inflammatory effect of milk fermented by a strain of IL-10-producing Lactococcus lactis using a murine model of Crohn’s disease | |
| WO2008114889A1 (en) | Oral vaccine | |
| O'Flaherty et al. | Functional and phenotypic characterization of a protein from Lactobacillus acidophilus involved in cell morphology, stress tolerance and adherence to intestinal cells | |
| Ogawa et al. | Oral immunoadjuvant activity of a new synbiotic Lactobacillus casei subsp casei in conjunction with dextran in BALB/c mice | |
| Rush et al. | Expression of vaccine antigens in Lactobacillus | |
| Havenith et al. | Gut-associated lactobacilli for oral immunisation | |
| Rottiers et al. | Modulation of gut-associated lymphoid tissue functions with genetically modified Lactococcus lactis | |
| Corthier et al. | Future directions for research on biotherapeutic agents: contribution of genetic approaches on lactic acid bacteria |